Start typing to see results...

Home
>
Stock Market
>
>
Beta Drugs Ltd

Beta Drugs Ltd share price and stock overview

Q: What is the NSE symbol and BSE code for Beta Drugs Ltd?

Beta Drugs Ltd trades on NSE under the symbol BETA and on BSE under code 535022. The ISIN is INE351Y01019 and the face value is Rs 10.

Beta Drugs Ltd (NSE: BETA, BSE: 535022) operates in the Pharmaceuticals - Indian - Bulk Drugs sector. The stock has an ISIN of INE351Y01019 and a face value of Rs 10. As of 11 July 2026, it trades at Rs (2,366.80) with a market capitalisation of Rs 2399.2 crore. Figures are live and subject to change.

Beta Drugs Ltd

Pharmaceuticals - Indian - Bulk Drugs

NSE BSE

2,366.80 176.50 (8.06%) upARrowC

As on: 11-Jul-2026 , 07:50 PM

Market Cap(₹Cr) 2399.2

Book Value(₹Cr) 147.5372525

BSE Code : 535022 NSE Symbol : BETA EPS(TTM) : 14.14 ISIN Demat : INE351Y01019 P/E(TTM) : 167.38 Face Value(₹) : 10 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

77,642.23

Todday's Low

77,320.56

Open at

77,395.63

Previous Close

76,741.82

Volumes

Avg Price

827.57

Historical Performance

News

14 May 26

Beta Drugs consolidated net profit rises 0.22% in the March 2026 quarter

Net profit of Beta Drugs rose 0.22% to Rs 9.05 crore in the quarter ended March 2026 as against Rs 9.

12 May 26

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 14 May 2026.

15 Feb 26

Beta Drugs consolidated net profit declines 4.80% in the December 2025 quarter

Net profit of Beta Drugs declined 4.80% to Rs 8.52 crore in the quarter ended December 2025 as against Rs 8.

14 Jan 26

Beta Drugs schedules EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 4 February 2026.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
10-07-26	2190.30	2395.00	2190.30	2366.80	95317	11611	220541357.10	24206.90
09-07-26	2008.50	2239.40	2008.50	2190.30	88056	11378	192565467.40	23962.80
08-07-26	2020.00	2104.50	1980.00	1998.00	22345	3498	45652627.30	23882.05
07-07-26	2148.00	2153.40	2052.30	2069.10	15448	2576	32205750.10	24398.70
06-07-26	2109.00	2184.40	2060.70	2153.40	23455	3524	50321475.10	24430.35
03-07-26	2165.20	2205.00	2076.70	2090.50	36025	3652	76725163.50	24270.85
02-07-26	2200.00	2207.00	2140.00	2155.70	8470	1356	18336977.50	24175.70
01-07-26	2195.60	2227.90	2108.50	2185.00	18332	2914	39684933.50	24005.85
30-06-26	2195.00	2240.00	2107.20	2184.70	27004	3135	59271584.70	23865.75
29-06-26	2099.90	2244.80	2099.90	2163.10	40825	4087	89061410.80	23946.25

12 3 ...

Fundamentals

Company Valuation

Market Cap (₹cr)

2399.2

PE Ratio

167.38

PB Ratio

16.04

Dividend Yield

ROE

15.30

ROCE

15.57

Book Value (₹)

147.5372525

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

0.00

Indian

Bodies Corporate-Indian (Promoter & Group)	0	0.00	0	0
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	6551392	59.10	6551392	5
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	0	0.00	0	0
Others	0	0.00	0	0

Sub Total

6551392

59.10

6551392

Total ShareHolding for Promoter & Group

6551392

59.10

6551392

Publice Share Holding

Institution

Government(Central / State)	0	0.00	0	0
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	0	0.00	0	0
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	327503	2.95	327503	8
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	0	0.00	0	0
Mutual Funds / UTI	0	0.00	0	0
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	666792	6.01	666792	6
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

994295

8.97

994295

Non Institution

Bodies Corporate	864695	7.80	864695	60
Clearing Members	1681	0.02	1681	7
Directors & their Relatives	0	0.00	0	0
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	97460	0.88	97460	205
Foreign Non Institution Other	0	0.00	0	0
Hindu Undivided Families	53046	0.48	53046	120
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	1123462	10.13	1123462	11
Individuals holding nominal share capital up to Rs. 1 lakh	1394966	12.58	1394966	4598
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	0	0.00	0	0
Others	0	0.00	0	0

Sub Total

3540185

31.93

3540185

5008

Total Public Shareholding

4534480

40.90

4534480

5022

Total of Promoter & Public ShareHolding

11085872

100.00

11085872

5027

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0

Total Shares held by Custodians and against which Depository Receipts have been issued

0.00

Grand Total

11085872

100.00

11085872

5027

Financials (₹ in cr)

Consolidated Standalone

Year End	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Net Sales	362.36	295.71	227.11	183.84	116.12
OPM (%)	16.98	16.49	18.08	18.66	13.74
OP	61.54	48.75	41.06	34.30	15.95
Other Income	6.44	1.36	0.75	0.76	0.50
PBIDT	76.47	61.36	53.88	43.45	25.24
INTEREST	6.99	2.82	2.41	1.90	2.42
PBDT	69.48	58.54	51.47	41.56	22.82
PBT	52.40	48.75	41.06	34.30	15.95
EO	-4.57	0.00	0.00	0.00	0.00
PBT after EO	56.97	48.75	41.06	34.30	15.95
TAXES	14.55	12.32	10.34	9.47	4.23
PAT	42.42	36.44	30.72	24.83	11.72
EPS	42.02	37.90	31.95	25.82	12.20
Raw Material	48.51	56.69	48.61	52.33	52.15
Power and Fuel	1.46	1.52	1.51	1.52	2.03
Employee Cost	9.36	8.75	9.99	8.65	9.37
Other Manufacturing Expenses	0.44	0.29	0.60	0.64	0.88
Selling and Administration Expenses	11.17	9.36	8.92	6.78	6.68
Miscellaneous Expenses	0.30	0.24	0.26	0.17	0.39
Revenue (Growth %)	22.54	30.21	23.54	58.31	27.88
PBIDT (Growth %)	24.64	13.87	23.99	72.14	37.81
PAT (Growth %)	16.42	18.62	23.73	111.76	24.53
PBIDT (Margin %)	21.10	20.75	23.72	23.64	21.74
PAT (Margin %)	11.71	12.32	13.53	13.51	10.10

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Share Capital	10.09	9.61	9.61	9.61	9.61	9.61
Reserves Total	118.94	106.40	86.64	67.85	53.80	46.83
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	129.03	116.01	96.25	77.46	63.41	56.44
Secured Loans	10.55	5.68	5.95	6.84	5.19	8.88
Unsecured Loans	117.00	0.00	0.00	0.00	0.00	0.03
Total Debt	127.55	5.68	5.95	6.84	5.19	8.91
Other Liabilities	6.16	3.18	2.59	2.44	1.82	0.86
Total Liabilities	262.74	124.87	104.79	86.74	70.42	66.21
APPLICATION OF FUNDS :
Gross Block	89.52	65.12	59.84	53.86	43.15	41.54
Less : Accumulated Depreciation	36.04	28.64	25.07	19.81	15.14	9.87
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	53.48	36.48	34.77	34.05	28.01	31.67
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	1.90	0.08
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	5.77	5.77	6.55	6.54	6.54	6.12
Current Assets, Loans & Advances
Inventories	27.44	21.94	13.66	8.47	7.70	6.10
Sundry Debtors	48.58	50.49	43.59	31.35	20.81	20.91
Cash and Bank Balance	141.99	27.20	17.79	15.58	8.27	4.16
Loans and Advances	22.30	14.05	9.95	7.35	6.78	6.00
Total Current Assets	240.31	113.68	85.00	62.76	43.55	37.17
Less : Current Liabilities and Provisions
Current Liabilities	54.08	43.74	26.31	22.22	15.23	15.42
Provisions	-0.30	1.87	2.94	1.94	0.57	0.56
Total Current Liabilities & Provisions	53.78	45.61	29.25	24.16	15.81	15.98
Net Current Assets	186.53	68.07	55.75	38.60	27.74	21.19
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1.10	0.81	0.89	0.60	0.37	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.03
Net Deferred Tax	1.10	0.81	0.89	0.60	0.37	-0.03
Other Assets	15.86	13.73	6.83	6.94	5.86	7.18
Total Assets	262.74	124.86	104.79	86.74	70.42	66.21
Contingent Liabilities	1.68	1.00	1.00	0.00	0.00	0.00

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Financing Activities	-4.34	1.27	-2.19	-0.76	118.20
Investing Activities	-3.15	-12.72	-5.82	-11.02	-21.46
Net Cash Flow	4.10	7.31	2.21	9.40	114.79
Operating Activities	11.60	18.76	10.23	21.19	18.04

Peers

Balance Sheet Financial Ratios Profit & Loss

No Data Available!!!

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
26th Mar 2025	Bonus	Bonus (Ratio =1:20)

Board of Directors

Chairman & Chief Executive Officer

Rahul Batra

Chairman & Managing Director

Executive

Functional Directors

Varun Batra

Joint Managing Director

Balwant Singh

Whole-time Director

WTD

Ashutosh Shukla

Whole-time Director

WTD

Ajay Mahipal

Non Executive Director

Exec.

Independent Directors

Rohit Parti

Independent Director

Ind.

Manmohan Khanna

Independent Director

Ind.

Sanjay Sehgal

Independent Director

Ind.

LKW

Lalit Kumar Watts

Independent Director

Ind.

Monica Jain

Independent Director

Ind.

Other Officials

Rajni Brar

Company Sec. & Compli. Officer

Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Beta Drugs Ltd? −

Beta Drugs Ltd trades on NSE under BETA and on BSE under code 535022. The ISIN is INE351Y01019 and the face value is Rs 10.

What is the share price of Beta Drugs Ltd today? +

As of 11 July 2026, Beta Drugs Ltd trades at Rs 2,366.80, a change of 176.50 (8.06%) on the day. Prices are live and subject to change.

What is the market capitalisation of Beta Drugs Ltd? +

As of 11 July 2026, Beta Drugs Ltd has a market cap of about Rs 2399.2 crore. This figure is live and moves with the share price.

Is Beta Drugs Ltd profitable? +

In March 2025, Beta Drugs Ltd reported a profit after tax of Rs 42.42 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Beta Drugs Ltd? +

: As of 11 July 2026, the PE (TTM) for Beta Drugs Ltd is 167.38 and the price-to-book ratio is 16.04. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Beta Drugs Ltd pay a dividend? +

As of 11 July 2026, the dividend yield for Beta Drugs Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Beta Drugs Ltd? +

As of the latest disclosed pattern, promoters hold 59.10% of Beta Drugs Ltd. Public shareholding is 40.90%, including mutual funds at 0.00% and foreign institutional investors at 2.95%.

What were the latest annual financials of Beta Drugs Ltd? +

In March 2025, Beta Drugs Ltd reported net sales of Rs 362.36 crore, revenue growth of 22.54%, and earnings per share of Rs 42.02.

Invest with clarity

on Chola Securities Mobile & Web App.

Stay organised, informed & in control while accessing your portfolio, reports, trading tools and service requests—all in one seamless platform.

Download the app now → The new app is listed as Chola Securities- Prime Access on App store & Google Play.
Also available on Web, Click to explore